HYOSCINE BUTYLBROMIDE INJECTION
HYOSCINE BUTYLBROMIDE INJECTION
Approved
DIN Number
02229868
Drug Class
Human
Market Date
Aug 21, 1997
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02229868
AIG Number0104703002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A03BB01 BUTYLSCOPOLAMINE
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intramuscular
,
Intravenous
AHFS Classification12:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
HYOSCINE BUTYLBROMIDEActive
Strength: 20 MG / ML
Monograph: HYOSCINE BUTYLBROMIDE